Novartis AG Free Cash Flow 2010-2024 | NVS

Novartis AG free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.

  • Novartis AG annual free cash flow for 2023 was $13.635B, a 1.16% increase from 2022.
  • Novartis AG annual free cash flow for 2022 was $13.478B, a 3.27% decline from 2021.
  • Novartis AG annual free cash flow for 2021 was $13.933B, a 11.79% increase from 2020.

Novartis AG Free Cash Flow 2010-2024 | NVS

  • Novartis AG annual free cash flow for 2023 was $13.635B, a 1.16% increase from 2022.
  • Novartis AG annual free cash flow for 2022 was $13.478B, a 3.27% decline from 2021.
  • Novartis AG annual free cash flow for 2021 was $13.933B, a 11.79% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$755.3B
Novo Nordisk (NVO)$392.1B
Johnson & Johnson (JNJ)$351.2B
AbbVie (ABBV)$318.1B
Merck (MRK)$251.6B
AstraZeneca (AZN)$205.6B
Pfizer (PFE)$151.5B
Sanofi (SNY)$122.6B
Bayer (BAYRY)$19.1B
Innoviva (INVA)$1.1B